ONESOURCE SPECIALTY PHARMA
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Income Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| INCOME : | ||||
| Gross Sales | ₹172 Cr | ₹39 Cr | ₹128 Cr | ₹128 Cr |
| Sales | - | - | - | - |
| Job Work/ Contract Receipts | - | - | - | - |
| Processing Charges / Service Income | ₹172 Cr | ₹39 Cr | ₹128 Cr | ₹128 Cr |
| Revenue from property development | - | - | - | - |
| Other Operational Income | - | - | - | - |
| Less: Excise Duty | - | - | - | - |
| Net Sales | ₹172 Cr | ₹39 Cr | ₹128 Cr | ₹128 Cr |
| EXPENDITURE : | ||||
| Increase/Decrease in Stock | - | - | - | - |
| Raw Material Consumed | ₹71 Cr | ₹20 Cr | - | - |
| Opening Raw Materials | ₹73 Cr | - | - | - |
| Purchases Raw Materials | ₹70 Cr | ₹94 Cr | ₹171 Cr | ₹171 Cr |
| Closing Raw Materials | ₹73 Cr | ₹73 Cr | ₹171 Cr | ₹171 Cr |
| Other Direct Purchases / Brought in cost | - | - | - | - |
| Other raw material cost | - | - | - | - |
| Power & Fuel Cost | ₹21 Cr | ₹21 Cr | ₹18 Cr | ₹18 Cr |
| Electricity & Power | ₹20 Cr | ₹20 Cr | ₹17 Cr | ₹17 Cr |
| Oil, Fuel & Natural gas | ₹0.13 Cr | - | ₹0.02 Cr | ₹0.02 Cr |
| Coals etc | - | - | - | - |
| Other power & fuel | ₹0.29 Cr | ₹0.46 Cr | ₹0.62 Cr | ₹0.62 Cr |
| Employee Cost | ₹79 Cr | ₹73 Cr | ₹53 Cr | ₹53 Cr |
| Salaries, Wages & Bonus | ₹68 Cr | ₹57 Cr | ₹46 Cr | ₹46 Cr |
| Contributions to EPF & Pension Funds | ₹4.42 Cr | ₹3.18 Cr | ₹2.33 Cr | ₹2.33 Cr |
| Workmen and Staff Welfare Expenses | ₹4.82 Cr | ₹7.07 Cr | ₹4.81 Cr | ₹4.81 Cr |
| Other Employees Cost | ₹1.96 Cr | ₹5.96 Cr | - | - |
| Other Manufacturing Expenses | ₹17 Cr | ₹17 Cr | ₹21 Cr | ₹21 Cr |
| Sub-contracted / Out sourced services | - | - | - | - |
| Processing Charges | ₹2.60 Cr | ₹3.56 Cr | ₹2.60 Cr | ₹2.60 Cr |
| Repairs and Maintenance | ₹15 Cr | ₹13 Cr | ₹14 Cr | ₹14 Cr |
| Packing Material Consumed | - | - | - | - |
| Other Mfg Exp | - | - | ₹4.89 Cr | ₹4.89 Cr |
| General and Administration Expenses | ₹65 Cr | ₹48 Cr | ₹30 Cr | ₹30 Cr |
| Rent , Rates & Taxes | ₹12 Cr | ₹1.96 Cr | ₹2.87 Cr | ₹2.87 Cr |
| Insurance | ₹4.49 Cr | ₹5.22 Cr | ₹2.82 Cr | ₹2.82 Cr |
| Printing and stationery | ₹0.64 Cr | ₹0.65 Cr | ₹0.92 Cr | ₹0.92 Cr |
| Professional and legal fees | ₹15 Cr | ₹17 Cr | ₹8.73 Cr | ₹8.73 Cr |
| Traveling and conveyance | ₹0.91 Cr | ₹1.15 Cr | ₹0.23 Cr | ₹0.23 Cr |
| Other Administration | ₹31 Cr | ₹22 Cr | ₹15 Cr | ₹15 Cr |
| Selling and Distribution Expenses | ₹0.90 Cr | ₹9.33 Cr | ₹1.50 Cr | ₹1.50 Cr |
| Advertisement & Sales Promotion | ₹0.50 Cr | ₹1.04 Cr | ₹0.94 Cr | ₹0.94 Cr |
| Sales Commissions & Incentives | - | - | - | - |
| Freight and Forwarding | ₹0.40 Cr | ₹8.29 Cr | ₹0.55 Cr | ₹0.55 Cr |
| Handling and Clearing Charges | - | - | - | - |
| Other Selling Expenses | - | - | - | - |
| Miscellaneous Expenses | ₹6.86 Cr | ₹11 Cr | ₹8.10 Cr | ₹8.10 Cr |
| Bad debts /advances written off | ₹0.07 Cr | ₹0.53 Cr | - | - |
| Provision for doubtful debts | - | - | - | - |
| Losson disposal of fixed assets(net) | ₹5.81 Cr | - | - | - |
| Losson foreign exchange fluctuations | ₹0.58 Cr | ₹9.16 Cr | ₹7.34 Cr | ₹7.34 Cr |
| Losson sale of non-trade current investments | - | - | - | - |
| Other Miscellaneous Expenses | ₹0.40 Cr | ₹1.47 Cr | ₹0.76 Cr | ₹0.76 Cr |
| Less: Expenses Capitalised | - | - | - | - |
| Total Expenditure | ₹260 Cr | ₹199 Cr | ₹132 Cr | ₹132 Cr |
| Operating Profit (Excl OI) | ₹-88 Cr | ₹-161 Cr | ₹-4.01 Cr | ₹-4.01 Cr |
| Other Income | ₹4.23 Cr | ₹2.69 Cr | ₹3.67 Cr | ₹3.67 Cr |
| Interest Received | ₹1.77 Cr | ₹1.47 Cr | ₹1.04 Cr | ₹1.04 Cr |
| Dividend Received | - | - | - | - |
| Profit on sale of Fixed Assets | - | - | ₹0.01 Cr | ₹0.01 Cr |
| Profits on sale of Investments | ₹0.76 Cr | ₹0.12 Cr | ₹1.64 Cr | ₹1.64 Cr |
| Provision Written Back | - | ₹0.01 Cr | ₹0.88 Cr | ₹0.88 Cr |
| Foreign Exchange Gains | - | - | - | - |
| Others | ₹1.70 Cr | ₹1.10 Cr | ₹0.10 Cr | ₹0.10 Cr |
| Operating Profit | ₹-84 Cr | ₹-158 Cr | ₹-0.34 Cr | ₹-0.34 Cr |
| Interest | ₹89 Cr | ₹48 Cr | ₹46 Cr | ₹46 Cr |
| InterestonDebenture / Bonds | - | - | - | - |
| Interest on Term Loan | ₹64 Cr | ₹37 Cr | ₹42 Cr | ₹42 Cr |
| Intereston Fixed deposits | - | - | - | - |
| Bank Charges etc | ₹4.05 Cr | ₹7.44 Cr | ₹4.15 Cr | ₹4.15 Cr |
| Other Interest | ₹22 Cr | ₹3.31 Cr | ₹0.15 Cr | ₹0.15 Cr |
| PBDT | ₹-173 Cr | ₹-206 Cr | ₹-47 Cr | ₹-47 Cr |
| Depreciation | ₹76 Cr | ₹66 Cr | ₹53 Cr | ₹53 Cr |
| Profit Before Taxation & Exceptional Items | ₹-250 Cr | ₹-271 Cr | ₹-100 Cr | ₹-100 Cr |
| Exceptional Income / Expenses | ₹-116 Cr | ₹-144 Cr | - | - |
| Profit Before Tax | ₹-366 Cr | ₹-416 Cr | ₹-100 Cr | ₹-100 Cr |
| Provision for Tax | - | - | ₹-0.11 Cr | ₹-0.11 Cr |
| Current Income Tax | - | - | ₹-0.11 Cr | ₹-0.11 Cr |
| Deferred Tax | - | - | - | - |
| Other taxes | - | - | - | - |
| Profit After Tax | ₹-366 Cr | ₹-416 Cr | ₹-100 Cr | ₹-100 Cr |
| Extra items | ₹-25 Cr | ₹-384 Cr | ₹-131 Cr | ₹-131 Cr |
| Minority Interest | - | - | - | - |
| Share of Associate | - | - | - | - |
| Other Consolidated Items | - | - | - | - |
| Consolidated Net Profit | ₹-391 Cr | ₹-800 Cr | ₹-231 Cr | ₹-231 Cr |
| Adjustments to PAT | - | - | - | - |
| Profit Balance B/F | ₹-1,431 Cr | ₹-631 Cr | ₹-401 Cr | ₹-401 Cr |
| Appropriations | ₹-1,822 Cr | ₹-1,431 Cr | ₹-632 Cr | ₹-632 Cr |
| General Reserves | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - |
| Corporate dividend tax | - | - | - | - |
| Other Appropriation | ₹0.53 Cr | ₹-0.48 Cr | ₹-0.28 Cr | ₹-0.28 Cr |
| Equity Dividend % | - | - | - | - |
| Earnings Per Share | ₹-97.55 | ₹-199.46 | ₹-76.14 | ₹-76.14 |
| Adjusted EPS | ₹-97.55 | ₹-199.46 | ₹-76.14 | ₹-76.14 |
Compare Income Statement of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹19,198.5 Cr | 1.6% | 3.8% | -17.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,179.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,095.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,530.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹114,318.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,742.1 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | 1.6% |
3.8% |
-17.2% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses